September 9, 2021
Earli is a diverse team united by a radical vision: Make Cancer A Benign Experience. At Earli, our team is developing a new approach to early cancer detection that applies state-of-the-art techniques from synthetic biology to force tumor cells in the body to reveal their location. It’s a mission that could save the lives of millions of people every year— and we still manage to enjoy the ride...Read More
July 21, 2021
Despite the progress made in treatment and prevention in recent years, cancer remains the number two killer in the United States after heart disease. The high mortality rates are largely due to the...
June 30, 2021
When Shereen Asad joined Earli as its sixth employee in 2019, her job description didn’t exactly say anything about selling human blood samples. The possibility never even crossed her mind...
June 7, 2021
The Covid-19 pandemic has taken over 3.4 million lives worldwide since 2020. Every single one of these deaths is a tragedy. By comparison, each year around three times as many people will die...
June 1, 2021
Take a hackathon and swap out the source code for genetic code. Add cell cultures, riboswitches, and RNA to the mix. Then give a team of gifted biologists 24 hours to develop a prototype or run an
May 26, 2021
Earli’s Scientific Advisory Board consists of some the brightest minds in oncology in the world, including directors of the world’s leading cancer research institutes and Nobel laureates for the
May 4, 2021
The global pandemic made the past year challenging in so many ways. But it’s important not to lose sight of the progress that was made in other areas despite the hardship.
March 23, 2021
Here's Earli co-founder and CEO Cyriac Roeding in a wide-ranging interview with Tough Tech Today podcast hosts Forrest Meyen and Jonathan Miller. Cyriac discusses Earli’s origins in the laboratories